Search references for CYTARABINE. Phrases containing CYTARABINE
See searches and references containing CYTARABINE!CYTARABINE
Chemical compound (chemotherapy medication)
Cytarabine, also known as cytosine arabinoside (ara-C), is a chemotherapy medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia
Cytarabine
Pharmaceutical drug
Daunorubicin/cytarabine, sold under the brand name Vyxeos, is a fixed-dose combination medication used for the treatment of acute myeloid leukemia. It
Daunorubicin/cytarabine
Acute myelogenous leukemia induction therapy regimen
duration of chemotherapy course, which consists of 7 days of standard-dose cytarabine, and 3 days of an anthracycline antibiotic or an anthracenedione, most
7+3_(chemotherapy)
Medication
For this purpose it is used with azacitidine, decitabine, or low-dose cytarabine for newly diagnosed adults who are age 75 years or older, or those with
Venetoclax
Cancer of the myeloid line of blood cells
participants. It showed the highest survival and remission rates, with low-dose cytarabine (LDAC) plus glasdegib and LDAC plus venetoclax also showing clinical benefit
Acute_myeloid_leukemia
Medical intervention
antimetabolite that, while not active toward AML, increases formation of an active cytarabine metabolite, ara-CTP, in AML cells; Arabinofuranosyl cytidine (or ara-C):
FLAG_(chemotherapy)
Pharmaceutical drug
trial for myelodysplastic syndromes in combination with idarubicin and cytarabine. It failed to demonstrate efficacy in treating acute myeloid leukemia
Vorinostat
Chemical that inhibits the use of a metabolite
following: 5-Fluorouracil (5-FU) 6-Mercaptopurine (6-MP) Capecitabine (Xeloda) Cytarabine (Ara-C) Floxuridine Fludarabine Gemcitabine (Gemzar) Hydroxycarbamide
Antimetabolite
Chemical compound
part of the FLAG or FLAMSA regimen, fludarabine is used together with cytarabine and granulocyte colony-stimulating factor in the treatment of acute myeloid
Fludarabine
Medical intervention
antigen CD20 Dexamethasone, a glucocorticoid hormone High-dose Ara-C - cytarabine, an antimetabolite; Platinol (cisplatin), a platinum-based antineoplastic
DHAP_(chemotherapy)
Chemical compound
vosaroxin plus cytarabine versus placebo plus cytarabine in adults with relapsed/refractory AML. In the VALOR study, vosaroxin combined with cytarabine did not
Vosaroxin
Topics referred to by the same term
District, Ivory Coast, also spelt "Da" DA (chemotherapy), standard-dose cytarabine plus daunorubicin Deoxyanthocyanidin Domoic acid, a neurotoxin produced
DA
German health company
oncology products, such as Paclitaxel, Irinotecan, Oxaliplatin, Gemcitabine, Cytarabine, Carboplatin, Topotecan, Docetaxel, and Epirubicin. Fresenius Vamed develops
Fresenius_(company)
Drugs that are useful against cancer
Vismodegib Azacitidine Azathioprine Capecitabine Cladribine Clofarabine Cytarabine Decitabine Doxifluridine Fludarabine Fluorouracil Gemcitabine Hydroxyurea
List of chemotherapeutic agents
List_of_chemotherapeutic_agents
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Mitomycin_C
Irish tax-registered pharmaceutical corporation
the rights to breakthrough therapy Vyxeos (liposomal daunorubicin and cytarabine) for treatment of acute myeloid leukemia. In August 2019, the company
Jazz_Pharmaceuticals
Chemotherapy medication
is usually performed together with other chemotherapy drugs (such as cytarabine), and its administration depends on the type of tumor and the degree of
Daunorubicin
Pharmaceutical drug classification
L01BB06 Clofarabine L01BB07 Nelarabine QL01BB90 Rabacfosadine L01BC01 Cytarabine L01BC02 Fluorouracil L01BC03 Tegafur L01BC04 Carmofur L01BC05 Gemcitabine
ATC_code_L01
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Talazoparib
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
High-dose_chemotherapy
Chemotherapy regimen for colorectal cancer treatment
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
FOLFIRI
Medical condition
antagonists (6-mercaptopurine, azathioprine) Pyrimidine antagonists (cytarabine) Phenytoin Nitrous Oxide Erythroleukemia Inborn genetic mutations of the
Megaloblastic_anemia
Family of chemical compounds
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Nitrogen_mustard
Chemotherapy medication
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Fluorouracil
Chemotherapy regimen
consists of monoclonal antibody rituximab and high-dose antimetabolite cytarabine. High-dose Ara-C (HDAC) without rituximab also has several other uses
R-HDAC
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Mitoxantrone
Species of sponge
pharmaceutical drugs vidarabine, which is used as an antiviral drug, and cytarabine which is used in the treatment of leukemia and lymphoma. As described
Tectitethya_crypta
Drug
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Proteasome_inhibitor
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Veliparib
Blood cancer characterized by overproduction of lymphoblasts
prophylaxis can be achieved via: cranio-spinal irradiation cytarabine + methotrexate or liposomal cytarabine In Philadelphia chromosome-positive ALL, the intensity
Acute_lymphoblastic_leukemia
Anthracycline antileukemic drug
"Resistance Mechanism of Acute Myeloid Leukemia Cells Against Daunorubicin and Cytarabine: A Literature Review". Cureus. 14 (12) e33165. doi:10.7759/cureus.33165
Idarubicin
Topics referred to by the same term
Age, an archaeological period IA (chemotherapy), with Idarubicin and cytarabine Ia (genus), of vespertilionid bats Phase Ia of a clinical trial Immunoassay
IA
Nonsteroidal anti-inflammatory medication
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Celecoxib
Pharmaceutical drug
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Valrubicin
the synthesis of zidovudine (AZT), aciclovir (Cyclovir), cytarabine (Depocyt), and cytarabine derivative gemcitabine (Gemzar). Semisynthetic analogs of
Sponge_isolates
Medication
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Lifileucel
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Busulfan
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Tioguanine
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Sapacitabine
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Tazemetostat
Pharmaceutical drug
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Belinostat
Phenomenon in genetics
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Crosslinking_of_DNA
Blood marrow cancer originating in megakaryoblast cells
induction therapy with cytarabine and daunorubicin followed by a single course of intensification therapy consisting of cytarabine and L-asparaginase, and
Acute megakaryoblastic leukemia
Acute_megakaryoblastic_leukemia
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Masoprocol
Gene therapy medication
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Obecabtagene_autoleucel
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Panobinostat
Industrial chemical and medication
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Arsenic_trioxide
Chemical compound; chemotherapy medication
vincristine administration occurred in China in 2007 when batches of cytarabine and methotrexate (both often used intrathecally) manufactured by the company
Vincristine
Diverse collection of blood-related cancers
showed increased survival compared to standard care (supportive care, cytarabine or chemotherapy) and is considered the standard of care. Azacitidine had
Myelodysplastic_syndrome
Chemotherapy medication
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Doxorubicin
Common side effects in chemotherapy treatment
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Chemotherapy-induced nausea and vomiting
Chemotherapy-induced_nausea_and_vomiting
Drug injected into the spinal canal
agents are licensed for intrathecal cancer chemotherapy: methotrexate, cytarabine, hydrocortisone, and thiotepa. Administration of any vinca alkaloids,
Intrathecal_administration
Chemical compound
antimetabolic agent against deoxycytidine (a component of DNA). It is the biologically active form of cytarabine. Ara-CTP - Compound Summary, PubChem. v t e
Arabinofuranosylcytosine triphosphate
Arabinofuranosylcytosine_triphosphate
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Mercaptopurine
Regimen commonly used in chemotherapy
daunorubicin, or IA or IAC in case of idarubicin use 7 days of Ara-C (cytarabine) plus 3 days of an anthracycline antibiotic, either daunorubicin (DA or
Chemotherapy_regimen
Drug for treatment of breast cancer
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Utidelone
Medication used for cancer
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Paclitaxel
Treatment for non-Hodgkin lymphoma
given in 21-day intervals, alternating with R-HDAC (rituximab + high-dose cytarabine). In most other non-Hodgkin lymphomas (excluding some aggressive forms)
CHOP_(chemotherapy)
Pharmaceutical drug
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Tebentafusp
Pharmaceutical drug
(5): 663–670. doi:10.1111/bjh.13955. PMID 26913480. The combination of cytarabine and cladribine is the current standard for second-line therapy of refractory
Cladribine
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Romidepsin
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Rabacfosadine
Medical condition
otherwise specified. It consists of chemotherapy, frequently consisting of cytarabine, daunorubicin, and idarubicin. It can also involve bone marrow transplantation
Acute_erythroid_leukemia
Medication
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Tretinoin
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Bortezomib
Anti-cancer medication
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Vorasidenib
Medication
Quizartinib is indicated, in combination with standard cytarabine and anthracycline induction and cytarabine consolidation, and as maintenance monotherapy following
Quizartinib
Biochemical compound
Ebolavirus, Marburg virus, Coronavirus cytidine and deoxycytidine analogues: cytarabine — chemotherapy gemcitabine — chemotherapy azacitidine — chemotherapy emtricitabine
Nucleoside_analogue
Medical intervention
infusion Second Methotrexate HD-MTX ~2500–8000 mg/m2 IV infusion Third Cytarabine HDAC or HD-AraC ~3000–6000 mg/m2 IV infusion Fourth Etoposide HD-ETO ~2000 mg/m2
Sequential high-dose chemotherapy
Sequential_high-dose_chemotherapy
Chemical compound
Chang C, He Q, Zhang X, et al. (September 2009). "Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen
Omacetaxine_mepesuccinate
Topics referred to by the same term
(chemotherapy), a chemotherapy regimen consisting of Daunorubicin, Ara-C (cytarabine) and Etoposide Daxing Airport Express, the airport transit service to
DAE
Enzyme used as medication and in food manufacturing
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Asparaginase
Chemical compound
reversed quiescence and decreased viability with addition of cytarabine than cytarabine alone. In OCI-AML3 and patient samples, only quiescence reversion
Nirogacestat
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Gemcitabine
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Glufosfamide
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Camptothecin
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Vatalanib
Medication used to treat cancer
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Carboplatin
Medication
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Decitabine/cedazuridine
Pharmaceutical drug
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Oxaliplatin
Adriamycin), and dexamethasone. Course B consists of methotrexate and cytarabine. The protocol was originally developed to treat leukemia in young, fit
Hyper-CVAD
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Lurbinectedin
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Dordaviprone
Treatment for acute myeloid leukemia
with low-dose cytarabine. The recommended dose of glasdegib is 100 mg orally once daily on days 1 to 28 in combination with cytarabine 20 mg subcutaneously
Glasdegib
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Navitoclax
Chemical compound
Chiao JW, Cai Z, Huang H, Liu D (November 2011). "A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute
Aclarubicin
Glycopeptide antibiotic used to treat various cancers
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Pingyangmycin
Hospital in New Territories, Hong Kong
22 days later. The patient was prescribed six oral drugs, intrathecal cytarabine and intravenous vincristine by another doctor, and was injected by the
Prince_of_Wales_Hospital
Chemotherapeutic agents used to treat cancer
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Platinum-based_antineoplastic
Pharmaceutical drugs
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Alkylating antineoplastic agent
Alkylating_antineoplastic_agent
Gene therapy medication
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Idecabtagene_vicleucel
Group of antibiotics
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Mitomycins
Gene therapy medication used to treat multiple myeloma
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Ciltacabtagene_autoleucel
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Bendamustine
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
4-Hydroxycyclophosphamide
Type of blood cancer
with the cytokine interferon-alpha. In the past, antimetabolites (e.g., cytarabine, hydroxyurea), alkylating agents, interferon alfa 2b, and steroids were
Chronic_myelogenous_leukemia
Cancer medication
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Temozolomide
Chemical compound
Fluorouracil# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine#) Hypomethylating
Vintafolide
Medical condition
R-DHAP (rituximab, dexamethasone, cytarabine, and cisplatin), R-ESHAP (rituximab, etoposide, methylprednisolone, cytarabine, and cisplatin), and dose-intensified
Richter's_transformation
Protein-coding gene in the species Homo sapiens
role of alternatively spliced deoxycytidine kinase in sensitivity to cytarabine of acute myeloid leukemic cells". Blood. 99 (4): 1373–80. doi:10.1182/blood
Deoxycytidine_kinase
travel, tourism, insurance
CYTARABINE
CYTARABINE
CYTARABINE
CYTARABINE
CYTARABINE
CYTARABINE
CYTARABINE
CYTARABINE
CYTARABINE
travel, tourism, insurance